Access cutting-edge chronic myelogenous leukemia - chronic phase treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Birmingham location
Preparing your pre-screening questions…
Access chronic myelogenous leukemia - chronic phase specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic myelogenous leukemia - chronic phase treatment provided free
Check if you qualify for this chronic myelogenous leukemia - chronic phase clinical trial in Birmingham, AL
No-Cost Study Care
Local to Birmingham
Convenient for AL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This CML disease registry (ASC4REAL-2) aims to gather evidence on the tolerability, safety, effectiveness, and patient-reported outcomes (PRO) in real-world healthcare from patients with Ph+-CML-CP treated with TKIs approved for 1L and 2L, including prospective follow-up for 5 years identifying and describing long-term treatment outcomes.
Sponsor: Novartis Pharmaceuticals
Yes, this clinical trial (NCT07091019) has an active research site in Birmingham, AL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic myelogenous leukemia - chronic phase treatment options in Birmingham, AL, this clinical trial (NCT07091019) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic myelogenous leukemia - chronic phase specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic myelogenous leukemia - chronic phase clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Birmingham — not just this study.
Browse Leukemia Trials in Birmingham →